Although it's been more than a year since Mount Augustine had its memorable eruption, work continues for University of Alaska Fairbanks researchers. The work of Alaska Volcano Observatory employees from UAF's Geophysical Institute will be appearing in the upcoming issue of the journal Science.

The Virginia Tech chemistry research group that has been creating molecular complexes that use solar energy to produce hydrogen from water has added an additional capacity to their supramolecule.

Karen Brewer, professor of chemistry, explains that the new, more robust molecules still harness light and covert it to chemical energy by splitting water to produce hydrogen. “What is different is the way the systems function. It is a three part molecule. The first part is a light absorber, harnessing visible and UV light. The second part is an electron reservoir. The third part is the catalysis to make hydrogen from water.” All of these sub-units are coupled into one large supramolecular assembly.

The impact of exercise on body fat differs for boys and girls, suggests research published ahead of print in the British Journal of Sports Medicine. Recommendations on exercise to curb the rising tide of obesity in children have tended to take a unisex approach, say the authors.

Well, almost predictable. The changes are consistent and occur at a predictable rate but because they are random, no one can predict exactly which new fashions will replace the old ones.

Huh?

“It’s like American Idol,” said Dr Alex Bentley, a Lecturer in the Anthropology Department at Durham University. “We can predict the steady production of new winners from programme to programme, but the randomness means we can’t forecast the particular winners themselves.”

Genetics tests could help provide cystic fibrosis (CF) patients with targeted treatment in future, pilot study authors suggest. Results from a French clinical trial published today in BMC Medicine show how a small percentage of CF sufferers with a rare genetic stop mutation responded positively to gentamicin treatment.

Aleksander Edelman and Isabelle Sermet-Gaudelus of Faculté de Médicine Necker in Paris led collaborators from several French institutions studying how the antibiotic gentamicin affected CF patients with a stop mutation. The team used a dual reporter gene assay first in vitro and then in CF patients.

A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.

Co-Principal Investigators, Dr. Gerard Cox, respirologist at St. Joseph’s Healthcare Hamilton’s Firestone Institute for Respiratory Health, and Professor at McMaster University, and Dr. John Miller, Division Head of Thoracic Surgery at St. Joseph’s Healthcare Hamilton and McMaster University authored the study. The study revealed improved asthma control at one year following the bronchial thermoplasty procedure.